amrinone has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryding, J | 1 |
| Heslet, L | 1 |
| Hartvig, T | 1 |
| Jønsson, V | 1 |
1 other study available for amrinone and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient.
Topics: Amrinone; Angiotensin II; Doxorubicin; Escherichia coli Infections; Female; Humans; Infusions, Intra | 1995 |